19659001 Mulligan, M. J. et al. Stage I/II research study of COVID-19 RNA vaccine BNT162b1 in grownups. 19459003 Nature 19459004 586, 589– 593 (2020 ). 19659002 Post PubMed CAS Google Scholar Morais, P., Adachi, H. & & Yu, Y.-T. The vital contribution of pseudouridine to mRNA COVID-19 vaccines. 19459003 Front. Cell Dev. Biol. 19459004 9, 789427 (2021 ). Short article PubMed Central Google Scholar Rohner, E., Yang, R., Foo, K. S., Goedel, A. & & Chien, K. R. Unlocking the pledge of mRNA therapies. Nat. Biotechnol. 19459004 40, 1586– 1600 (2022 ). 19659006 Post PubMed CAS Google Scholar 19659007 Jackson, R. J., Hellen, C. U. T. & & Pestova, T. V. The system of eukaryotic translation initiation and concepts of its policy. 19459003 Nat. Rev. Mol. Cell Biol. 11, 113– 127 (2010 ). 19659008 Short article PubMed Central CAS Google Scholar von der Haar, T., Gross, J. D., Wagner, G. & & McCarthy, J. E. G. The mRNA cap-binding protein eIF4E in post-transcriptional gene expression. Nat. Struct. Mol. Biol. 19459004 11, 503– 511 (2004 ). 19659010 Short article PubMed Google Scholar Despic, V. & & Jaffrey, S. R. mRNA aging shapes the Cap2 methylome in mammalian mRNA. 19459003 Nature 614, 358– 366 (2023 ). 19659012 Short article PubMed Central CAS Google Scholar Züst, R. et al. Ribose 2 ′- 19459003 O -methylation supplies a molecular signature for the difference of self and non-self mRNA based on the RNA sensing unit Mda5. 19459003 Nat. Immunol. 19459004 12, 137– 143 (2011 ). 19659014 Post PubMed Central Google Scholar Ramanathan, A., Robb, G. B. & & Chan, S.-H. mRNA topping: biological functions and applications. Nucleic Acids Res. 44, 7511– 7526 (2016 ). Short article PubMed Central Google Scholar Grudzien‐Nogalska, E. et al. Synthesis of anti‐reverse cap analogs (ARCAs) and their applications in mRNA translation and stability. 19459003 Techniques Enzymol. 19459004 431, 203– 227 (2007 ). 19659018 Short article PubMed Google Scholar Stepinski, J., Waddell, C., Stolarski, R., Darzynkiewicz, E. & & Rhoads, R. E. Synthesis and residential or commercial properties of mRNAs including the unique ‘anti-reverse' cap analogs 7-methyl(3 ′- O 19459004 -methyl)GpppG and 7-methyl(3 ′-deoxy)GpppG. 19459003 RNA 19459004 7, 1486– 1495 (2001 ). 19659020 PubMed Central CAS Google Scholar 19659021 Ishikawa, M., Murai, R., Hagiwara, H., Hoshino, T. & & Suyama, K. Preparation of eukaryotic mRNA having actually in a different way methylated adenosine at the 5 ′-terminus and the impact of the methyl group in translation. Nucleic Acids Symp. Ser. 19459004 53, 129– 130 (2009 ). 19659022 Short article CAS Google Scholar 19659023 Sikorski, P. J. et al. The identity and methylation status of the very first transcribed nucleotide in eukaryotic mRNA 5 ′ cap regulates protein expression in living cells. Nucleic Acids Res. 19459004 48, 1607– 1626 (2020 ). Post PubMed Central CAS Google Scholar 19659025 Jurga, S. & & Barciszewski, J. (eds) Messenger RNA Therapeutics 19459004 (Springer Nature, » … 19659027 Learn more 19459033
